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Islet or insulinoma myloid polypeptide (IAPP) is a 37 amino acid polypeptide isolated from pancreatic amyloid. Here, 
we describe the isolation and partial characterization f the human gene encoding IAPP. The DNA sequence predicts 
that IAPP is excised from a larger precursor protein and that its carboxy-terminus is probably amidated. The predicted 
normally occurring IAPP is identical to the reported polypeptides isolated from pancreatic amyloid, except for the ami- 
dated carboxy-terminus. IAPP specific polyadenylated RNAs of 1.6 kb and 2.1 kb are present in human insulinoma 
RNA. The human IAPP gene is located on chromosome 12. 
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1. INTRODUCTION 
Amyloid is a pathological deposit of peptide 
subunits arranged in p-pleated sheet fibrils. It is 
commonly found in pancreatic islets of patients 
with diabetes mellitus type 2 (non-insulin- 
dependent) and in insulinomas. Recently, islet or 
insulinoma amyloid polypeptide (IAPP) was 
isolated as a major constituent of amyloid present 
in a human insulinoma [I,2]. IAPP was also 
isolated from islet amyloid in a human type 2 
diabetic patient and in the diabetic cat [2,3]. A 
similar polypeptide, termed diabetes associated 
peptide (DAP), was also isolated from islet 
aYi?jItiti iG,5>. MY%&? YX&> >LW~ XL& Z=+@ rZp* 
sews 1%~ same p&p@i&. 
Human IAPP (hIAPP) is 37 amino acids long 
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with cysteine residues in positions 2 and 7. These 
features are also found in all known calcitonin 
gene-related peptides (CGRPs) [6-81. Further- 
more, hIAPP shows 46% amino acid sequence 
homology with hCGRP-II [2,5,9]. IAPP has been 
demonstrated immunochemically in normal P-cells 
of several mammals [2,4,10]. These data suggest 
that IAPP has important hormonal significance 
with respect lo pancreatic islet function and is ex- 
pressed from a gene distantly related to the 
calcitonin gene family. 
The isolation and chromosomal localization of 
the human IAPP gene are presented in this report. 
Furthermore, expression of this gene in a human 
&$YXKWT~ Was L&%i%& L”3’ >:W &%X&i? ZL+ 
I.%W spi&fic @ja&&aM RW& 0p1 a 
Northern blot. Investigations of the structure and 
expression of the IAPP gene are of importance 
with respect to pancreatic amyloid formation and 
-WMi rwpect ta l&Z? e&&on of tk ea&eti*?J 
CGRP QZALCj gene family. 
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2. MATERIALS AND METHODS 
2.1. Phage A library of human genomic DNA 
An amplified human genomic library in XEMBL3 [ll], 
prepared from chromosomal DNA from chronic myeloid 
leukemia cells, was kindly provided by Dr Cl. Grosveld 
(Erasmus University, Rotterdam, The Netherlands). 
2.2. Oligonucleotides ( ee fig. I) 
Oligonucleotide IAPP I- 18 corresponds to amino acids 1- 18 
of hIAPP [5]. Oligonucleotide IAPP 30-39 corresponds to 
amino acids 30-37 [5], whereas a glycine residue was predicted 
in position 38 and an arginine residue in position 39. These 
residues are highly conserved in all known CGRP precursors 
[6-81. The nucleotide sequences of the oligonucleotides were 
selected using the criteria of Lathe [12]. Oligonucleotide CGRP 
12-21 is 100% homologous to the regions encoding amino acids 
12-21 of hCCiRP-I and -11 [6]. 
2.3. Oligonucleotide labeling 
Labeled oligonucleotide probes were synthesized on template 
oligonucleotides by elongation of hybridized primers (see fig. 1), 
using the Klenow fragment of DNA polymerase I [13]. 
[a-‘*P]dGTP (IAPP 30-39) or [a-s’P]dCTP (IAPP l-18 and 
CGRP 12-21) was incorporated during the reaction. A mixture 
of 8 pmol primer and 6 pmol template oligonucleotide in 
10 mM Tris-HCl, pH 8.5/10 mM MgClz and 0.1 mM of each 
of the unlabeled dNTPs was heated to 95°C for 3 min and 
allowed to cool to 20°C. The mixture was added to 250&i 
[a-3ZP]dGTP or [cu-32P]dCTP, which had been dried in ad- 
vance. After the addition of Klenow enzyme (5 U, Pharmacia) 
the mixture was incubated for 45 min at 16”C, 45 min at 20°C 
and 30 min at 37°C. A chase reaction was performed by the ad- 
dition of dGTP or dCTP to 0.1 mM and incubation for 15 min 
at 37°C. Due to the difference in length, the labeled strand 
could be separated from the unlabeled template strand on a 
10% polyacrylamide/7 M urea gel. After autoradiography, the 
labeled strand was excised from the gel and eluted for 2 h in 
10 mM Tris-HCl, pH 7.5/l mM EDTA. The specific activity of 
the oligonucleotide probes was 6-7 x IO9 dpm/hg. 
2.4. Plaquelifts, Northern blotting, Southern blotting and 
hybridizations 
One million plaques were screened on Hybond-N membranes 
(Amersham) at a density of 35000/135 mm filter. Plaquelifts 
were made as described by the supplier. RNA was isolated from 
a human insulinoma [14] and used for a Northern blot on a 
Hybond-N membrane [15]. Southern blotting of agarose gels 
was performed on Hybond-N membranes overnight, using 20 x 
SSC, as described in [16]. Double-stranded DNA probes were 
labeled by random priming [17] using [cu-3ZP]dCTP. Hybridiza- 
tion of membranes with probes was performed in the presence 
of 50% formamide and 6 x SSC overnight at 30°C (probes 
IAPP 30-39 and CGRP 12-21), at 35°C (IAPP I-18) or at 
42°C (ds-DNA probes). Filters were washed in 2 x SSC, 2 x 
30 min at hybridization temperature, except for filters hybrid- 
ized with ds-DNA probes (2 x SSC/O.S% SDS at 65”C, 2 x 
30 min). Filters were exposed to Fuji RX films using intensify- 
ing screens. As an IAPP-specific probe we used a PstI-BamHI 
fragment, which contains 4 nucleotides of the Ml3 polylinker 
and nucleotides 8-171 (see fig.2). 
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2.5. Nucleotide sequence analysis and chromosomal 
assignment 
The 170 bp Sau3A and the 570 bp AluI fragments subcloned 
in Ml3 mp9 were sequenced using the dideoxy-nucleotide chain- 
termination method [18]. ds-DNA fragments of these clones 
were labeled 5’-terminally using [y-“P]ATP and Tq kinase and 
sequenced according to the chemical modification method [19]. 
The method used for the chromosomal assignment of a human 
gene has been described [20]. A Southern blot prepared from 
TaqI-digested DNA from 14 human-Chinese hamster and 2 
human-mouse somatic cell hybrids was hybridized to the PstI- 
BarnHI probe. 
3. RESULTS 
Plaquelift filters were successively hybridized 
with the oligonucleotide probes listed in fig.1. 
Under low stringency hybridization conditions, 
these oligonucleotides each detect many genomic 
clones (100-200). One clone (Ah201) hybridized to 
both oligonucleotides IAPP 1-18 and IAPP 
30-39, but not with oligonucleotide CGRP 12-21. 
33 clones were identified as CALC-I or CALC-II 
clones because of their strong hybridization with 
the CGRP 12-21 oligonucleotide probe. Nucle- 
otide sequence analysis of a 570 bp A/u1 and a 
170 bp Sau3A fragment, obtained by subcloning 
h201 in Ml3 mp9, reveals the DNA sequence 
shown in fig.2. 
The deduced amino acid sequence of part of the 
genomic A/u1 fragment of Ah201 (nucleotides 
75-185 in fig.2) predicts a 37 amino acid polypep- 
tide identical to the polypeptides isolated from 
pancreatic amyloid [2,5]. Apparently, hIAPP is 
cleaved from a larger precursor polypeptide at the 
proteolytic processing sites Lys-Arg (nucleotides 
69-74) and Gly-Lys-Arg (nucleotides 186- 194), 
the latter being a combined site for proteolytic 
cleavage and subsequent amidation of the 
preceding amino acid. The carboxy-terminal 
polypeptide of the hIAPP precursor is 16 amino 
acids long, which might be cleaved at the Lys-Arg 
proteolytic site corresponding to nucleotides 
213-218. These data clearly indicate that hh201 
contains (part of) the human IAPP gene. The 
oligonucleotide probes used to identify this gene 
are 86% (IAPP 30-39) and 76% (IAPP 1-18) 
homologous to the corresponding parts of the 
IAPP gene. 
The PstI-BamHI probe hybridizes with an 11 kb 
EcoRI, a 9 kb PstI and a 4.0 kb TaqI fragment on 
a Southern blot of human genomic DNA (fig.3). 
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5’ ~CCAA~GTG~G~TCCAACA~CTATGGCAG~ 3 
9 ATACCGTC 5 
5’ ~AGTGCAAC~CAGCCACCT~TGCCAC~~A~ 
~GGCTGGCC~ACTTCCTGG~GCACT~ 8 
3’ AAGGACCACGTG 5’ 
5 ~TGGCAGGCYTGCTGAGCA~ATCAGGGGF! 3’ 
3’ TAGTCCCC 5’ 
Fig.]. Sequences of oligonucleotides IAPP 30-39, IAPP l-18, CGRP 12-21 and their respective primers. Primers are elongated using 
Klenow polymerase. Incorporation of labeled dNTPs results in a labeled strand, which can be separated from the template 
oligonucleotide, due to the difference in length. 
1 10 20 30 40 50 I 
GATCCAGCTAAAATTCTPGCTCTMCTTTTCACACTTTGTTCCATGTTACCAGT CAT 
His 
-6 
G1 1 
El 
60 90 100 
CAG GTG GAA AAG CGG AAA TGC AAC ACT GCC ACA TGT GCA ACG CAG 
Gln Val Glu Lys Arg Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln 
1 10 
110 120 130 140 
CGC CTG GCA AAT TTT TTA GTT CAT TCC AGC AAC MC TTT GGT GCC 
Arg Leu Ala Asn Phe Leu Val His Ser Ser Asn Asn Phe Gly Ala 
20 
160 170 160 
ATTr cre red rcr ALL- 6x Grc; GGn: rcc ddr dcd rdr&ZZXf 
Ile Leu Ser Ser Thr Asn Val Gly Ser Asn Thr Tyr Gly Lys Arg 
30 37u 
200 210 230 
AATT h-d Grd GdG Grr TrdatGdG Ed CE MT Tdc ffG CCC 
Asn Ala Val Glu Val Leu Lys Arg Glu Pro Leu Asn Tyr Leu Pro 
I 50 
250 
CTU rdG dGGdcAArGrAAcrcdrdrGrdrrrc;rrrrdrGrrcdrGrGdrrrccrGrA 
Leu End End 
300 350 
TAATTTMCAGTGCCCTTTCAATCTCCAGTGTGMTATATGGTCTGTGTGTCTGATGTT 
400 
450 
CCATmGATAGTATCTTTTAAAATGAAATGTTTTTGCTATAGATTTGTATTTl 
500 
550 570 
GAGAAAAAGGTAGTTTGAACCTTGTTMTTGTAAACAG 
Fig.2. Nucleotide sequence of part of the human IAPP gene. 
Putative 3’splice sites are indicated by arrows. Translation 
from nucleotide 56 downstream reveals part of the IAPP 
precursor. Potential proteolytic processing sites are boxed. The 
stop codon (243-245; end) is followed by a second stop codon 
in the same reading-frame (255-258; end). A putative 
polyadenylation signal (419-424) is underlined. The 170 bp Sau 
fragment corresponds to nucleotides l-171; the 570 bp AIn1 
fragment to nucleotides 8-57 1. 
On a Northern blot containing RNA isolated from 
a human insulinoma, the same probe detected two 
polyadenylated RNA species of 1.6 and 2.1 kb, 
respectively (fig.4). Hybridization of TaqI- 
digested DNA of human-rodent somatic cell 
hybrids with the hIAPP probe reveals the presence 
of the human IAPP gene on chromosome 12 (table 
1). Two hybrids were available containing 
chromosomes derived from the reciprocal 
- 4.0 
-2100 
-1600 
Fig.3. (Left) Southern blot analysis of human chromosomal 
DNA digested with TaqI (lane l), PstI (lane 2) and EcoRI (lane 
3) hybridized with the PM-BamHI probe (see section 2). Sizes 
of hybridizing fragments are indicated in kilobases (kb). 
Fig.4. (Right) Northern blot analysis of RNA isolated from a 
human insulinoma. Total cellular (3.3 pg, lane 1) and poly(A)- 
enriched (3 yg, lane 2) RNA preparations were hybridized with 
the PstI-BamHI probe (see section 2). 
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Table 1 
Segregation of the human IAPP locus with human 
chromosomes in 16 human-rodent somatic cell hybrid clones 
Chromosome Chromosome/IAPP locus % dis- 
cordance 
+/+ +/- -/+ -/- 
1 7 4 4 1 50 
2 2 1 9 4 63 
3 7 2 4 3 38 
4 5 2 6 3 50 
5 7 2 4 3 38 
6 3 2 8 3 63 
7 6 I 5 4 38 
8 7 4 4 1 50 
9 6 2 5 3 44 
10 5 1 6 4 44 
11 6 5 5 0 63 
12 10 0 1 5 6 
13 6 1 5 4 38 
14 8 1 3 4 25 
15 9 2 2 3 25 
16 8 4 3 1 44 
17 10 3 1 2 25 
18 3 2 8 3 63 
19 6 4 5 1 56 
20 9 2 2 3 25 
21 7 4 4 1 50 
22 7 3 4 2 44 
X 8 3 3 2 38 
Numbers in columns indicate the number of hybrid clones 
which contain both the numbered chromosome and the IAPP 
gene (+ / + ), the numbered chromosome but not the IAPP 
gene (+I-), the IAPP gene but not the numbered 
chromosome (- / +), or neither the numbered chromosome nor 
the IAPP gene (- / -) 
containing the qlCpter part of chromosome 12 
was positive for IAPP. AlWCB containing the 
ql4-qter part of chromosome 12 was negative for 
IAPP (not shown). 
4. DISCUSSION 
We have isolated from a human genomic library 
the gene encoding hIAPP by (i) usage of two 
oligonucleotide probes corresponding to different 
parts of the amino acid sequence of hIAPP and (ii) 
labeling of oligonucleotide probes to a high 
specific activity using the primer extension 
method. 
IAPP is a major constituent of pancreatic 
amyloid and since amyloid is found in the majority 
230 
of type 2 diabetic patients as well as in in- 
sulinomas, an important role is suggested for 
IAPP in the pathogenesis of pancreatic islet 
dysfunction. The deduced amino acid sequence of 
the IAPP encoding part of the gene reveals that the 
normally occurring polypeptide is identical to the 
polypeptides isolated from pancreatic amyloid 
[2,5]. This observation implies that amyloid is not 
formed due to the presence of a mutated form of 
IAPP, as has been hypothesized [5]. The glycine 
residue following Tyr-37 indicates that, like all 
known CGRPs and calcitonins, hIAPP is probably 
carboxy-terminally amidated. This has not been 
reported by the amino acid sequence analysis, but 
it is in agreement with the reported problems con- 
cerning the carboxy-terminal identification with 
carboxypeptidase Y [S]. Amidation of IAPP is 
probably important for studies on the 
physiological role of IAPP. 
Like many other polypeptide hormones mature 
IAPP is processed from a larger precursor protein 
at Lys-Arg proteolytic cleavage sites. When we 
compare the deduced amino acid sequence of the 
IAPP precursor (fig.2) with the reported deduced 
sequences of CGRP precursors [6-81, it appears 
that IAPP (amino-terminally cleaved) and the 
CGRPs are cleaved at a Lys-Arg proteolytic site. 
The highly conserved Gly-Arg-Arg-Arg-Arg se- 
quence at the carboxy-terminus of the CGRPs is 
replaced by Gly-Lys-Arg in the IAPP precursor. 
The deduced carboxy-terminal peptides of the 
known CGRP precursors consist of four amino 
acids, whereas the IAPP carboxy-terminal peptide 
is 16 amino acids long, and is possibly cleaved to 
form two small peptides of 6 and 8 amino acids. 
Whether these have physiological functions, re- 
mains to be determined. 
The IAPP gene probably is a single copy gene in 
the human genome, because only one genomic 
EcoRI, PslI or TaqI fragment is detected with the 
IAPP-specific probe. Since the polypeptide is pre- 
sent in pancreatic islets and in insulinomas, this 
gene is supposed to be expressed in pancreatic ,& 
cells. In a human insulinoma two IAPP-specific 
RNA species of approx. 1.6 and 2.1 kb have now 
been detected. The presence of two different 
polyadenylated IAPP RNAs in this tissue remains 
to be investigated. The IAPP RNAs are rather 
large in comparison to the human CGRP mRNAs 
(1.1-1.2 kb) [22,23]. 
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We assume that hIAPP is encoded by an exon 
starting at position 56 or position 63 (in fig.2). 
Both potential 3 ‘-splice sites resemble the consen- 
sus sequence (Py),NCAG [24]. Splicing between 
nucleotides 55 and 56 would result in an exon start- 
ing at exactly the same distance (19 nucleotides) 
upstream of the hIAPP- and hCGRP-encoding se- 
quences, respectively. Two potential branch point 
sequences are present (positions 14-20 and 
22_25}, .&i.&. .#&d re$V.*.+ . P.-1 c :.. !xadl4ng 3s she A - 
residues at positions 19 or 27 ( - 37 and -29, 
respectively). It is unclear whether this putative ex- 
on is spliced at the 3’-end or whether the potential 
poly(A) addition signal at position 419-424 is 
used. The sequence information of an TAPP 
cCKA wi(l be impartant in this respect. 
The hIAPP gene was assigned to chromosome 
12 using the human-rodent somatic cell hybrid 
tec+afiizz*. ctif?& rw&rih< +&&&i,, m+ifg 
hybrids containing translocation-derived chromo- 
somes, placed the IAPP locus within the ql4-pter 
region. The gene is thus not located in close prox- 
imity to the related CALC-I, CALC-II and CALC- 
III genes, which were assigned to chromosome 1 I 
[20,25,26]. This observation implies that the exon 
2- and 3-like sequences of CALC-III [26] are not 
directly related to the IAPP gene. Probably the 
IAPP gene arose by duplication and translocation 
to chromosome 12 of a progenitor CALC-gene and 
subsequent sequence divergence. An evolutionary 
relationship between chromosomes 11 and 12 has 
been suggested [27]. 
The availability of DNA probes may be impor- 
tant in determining the role of IAPP in normal 
pancreatic islet function and its possible role in the 
pathogenesis of type 2 diabetes mellitus. The 
re~&&zrre, -d -flfL flJf Qlz I&?p ge?p, er, <+K 
CALC genes makes it tempting to consider the 
possibility of the IAPP gene revealing alternative 
RNA processing, since this phenomenon occurs in 
the CALC-I gene. 
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